BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37271529)

  • 1. [Current status and future perspective of treatment for hemophilia].
    Kashiwakura Y; Ohmori T
    Rinsho Ketsueki; 2023; 64(5):377-388. PubMed ID: 37271529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The More Recent History of Hemophilia Treatment.
    Franchini M; Mannucci PM
    Semin Thromb Hemost; 2022 Nov; 48(8):904-910. PubMed ID: 36108649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2017 Clinical trials update: Innovations in hemophilia therapy.
    Hartmann J; Croteau SE
    Am J Hematol; 2016 Dec; 91(12):1252-1260. PubMed ID: 27563744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [NEW INNOVATIONS IN THE TREATMENT OF HEMOPHILIA].
    Levy-Mendelovich S; Brutman-Barazani T; Kenet G
    Harefuah; 2023 Jan; 162(1):47-51. PubMed ID: 36714942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming the challenges of treating hemophilia in resource-limited nations: a focus on medication access and adherence.
    Ghosh K; Ghosh K
    Expert Rev Hematol; 2021 Aug; 14(8):721-730. PubMed ID: 34278926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylaxis for hemophilia A without inhibitors: treatment options and considerations.
    Valentino LA; Khair K
    Expert Rev Hematol; 2020 Jul; 13(7):731-743. PubMed ID: 32573295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New therapies using nonfactor products for patients with hemophilia and inhibitors.
    Nogami K; Shima M
    Blood; 2019 Jan; 133(5):399-406. PubMed ID: 30559263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Evolution of Hemophilia Care: Clinical and Laboratory Advances, Opportunities, and Challenges.
    Trinchero A; Sholzberg M; Matino D
    Hamostaseologie; 2020 Aug; 40(3):311-321. PubMed ID: 32726826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the treatment of bleeding disorders.
    Peyvandi F; Garagiola I; Biguzzi E
    J Thromb Haemost; 2016 Nov; 14(11):2095-2106. PubMed ID: 27590165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.
    Stobart K; Iorio A; Wu JK
    Cochrane Database Syst Rev; 2006 Apr; (2):CD003429. PubMed ID: 16625581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the development of coagulation factors and procoagulants for the treatment of hemophilia.
    Schaub RG
    Biochem Pharmacol; 2011 Jul; 82(2):91-8. PubMed ID: 21453683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis and management of hemophilia].
    Tokugawa T
    Rinsho Ketsueki; 2020; 61(9):1338-1348. PubMed ID: 33162534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longer-acting clotting factor concentrates for hemophilia.
    Powell JS
    J Thromb Haemost; 2015 Jun; 13 Suppl 1():S167-75. PubMed ID: 26149018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.
    Stobart K; Iorio A; Wu JK
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003429. PubMed ID: 15846666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor VIII therapy for hemophilia A: current and future issues.
    Aledort L; Ljung R; Mann K; Pipe S
    Expert Rev Hematol; 2014 Jun; 7(3):373-85. PubMed ID: 24717090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status and future prospects for the prophylactic management of hemophilia patients with inhibitor antibodies.
    Teitel JM; Sholzberg M
    Blood Rev; 2013 Mar; 27(2):103-9. PubMed ID: 23452718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innovations in coagulation: improved options for treatment of hemophilia A and B.
    Pabinger-Fasching I; Pipe S
    Thromb Res; 2013 Mar; 131 Suppl 2():S1. PubMed ID: 23537720
    [No Abstract]   [Full Text] [Related]  

  • 19. How I use bypassing therapy for prophylaxis in patients with hemophilia A and inhibitors.
    Leissinger CA; Singleton T; Kruse-Jarres R
    Blood; 2015 Jul; 126(2):153-9. PubMed ID: 25827834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive care for hemophilia and other inherited bleeding disorders.
    Page D
    Transfus Apher Sci; 2019 Oct; 58(5):565-568. PubMed ID: 31427262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.